It really has been disturbing for me , it even affects my sleep and I do not snore .
I invested in this 2 years ago , they had a seemingly great product with efficacy higher than other mandibular devices , but my expectations of huge increases in revenue did not eventuate yet the cash burn up to the last quarter has been what I consider to be very high .
Unless the company can show that revenue is going gang busters , I doubt this current business model of staying solvent by constantly going back to shareholders for funding is sustainable as shareholders will want to see light at the end of the tunnel , not just contracts that seem to not flow through into revenue .
Those running the company are intelligent sincere people so I suspect it is very disturbing for them to, to see the slow growth in sales and they must be puzzled as to why sales are not ramping up faster
From another perspective I am looking to go into the USA with a new product so if I can learn what OVN did wrong in its marketing it could be helpful for me , I know one thing to keep my fixed costs down by not basing my operations in California but rather in the Southern non unionised States .
OVN Price at posting:
9.0¢ Sentiment: Hold Disclosure: Held
